White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 16: Consumer and Employee Interactions
RC-approved consumer materials for use at patient education programs which are organized and
conducted by third parties. Slide decks should not be shared unless the relevant RC has specifically
authorized dissemination of the slide deck in this manner. You cannot offer any speaker payment or
other financial support for the non-Pfizer programs, including, but not limited to, providing food or
equipment for these non-Pfizer programs.
Consumer Privacy
Pfizer recognizes the importance of safeguarding the confidentiality of Personal Information (PI),
including Sensitive Personal Information (SPI). SPI is health-related information that, in combination
with certain identifiers, such as name, birth date or social security number, can be used to identify a
specific individual. As a colleague, you must not seek SPI about consumers when you are interacting
with them. In the event you encounter SPI in the course of interacting with a consumer, do not disclose
or use such information for any purpose or in any manner that would compromise the confidentiality of
such SPI. For a detailed discussion of privacy issues, see Orange Guide Chapter 8: Privacy: Protecting
Personal Information.
Other Consumer Interactions
Consumer interactions that are not described in this Field Guide as being permissible are not
appropriate for you to engage in. Before engaging in any consumer interaction other than those
discussed here please confer with your manager or Regional Attorney.
FOR MORE INFORMATION
For more information on handling suspected adverse events, visit the PfieldNet Compliance
Page at http://PfieldNet.pfizer.com/Compliance and select “Handling Reports of Suspected
Adverse Events,” listed under Stay in Compliance.
For more information about Pfizer’s policies and procedures for conducting speaker
programs for consumers, please refer to EZSpeak.
Questions may be referred to your manager or Regional Attorney.
246
Rev. 09/12
Page 14 of 14